Anti-Diabetic Drugs Suppressing Appetite Leads to Declines in Beer and Snack Stocks

Anti-diabetic drugs like Ozempic are causing declines in beer and snack stocks as they suppress appetite and lead to less grocery purchases.

Walmart has data showing customers on these medications are buying fewer items and calories.

Stocks dropped significantly on Friday for companies like Nestle, Mondelez, Kraft Heinz, JM Smucker, Constellation Brands, and Kellanova.

Novo Nordisk and Eli Lilly have seen huge sales growth in 2022 from weight loss drugs like Ozempic and Mounjaro.

Morgan Stanley estimates 7% of the U.S. population could be on these drugs by 2035, potentially cutting daily calorie intake by 30%.